Shares of Semper Paratus Acquisition Corporation (NASDAQ:TVGN - Get Free Report) were down 2.4% during mid-day trading on Tuesday . The company traded as low as $1.20 and last traded at $1.22. Approximately 313,027 shares traded hands during trading, a decline of 94% from the average daily volume of 5,060,446 shares. The stock had previously closed at $1.25.
Wall Street Analysts Forecast Growth
Separately, D. Boral Capital reiterated a "buy" rating and set a $10.00 target price on shares of Semper Paratus Acquisition in a report on Wednesday, June 18th.
Check Out Our Latest Analysis on TVGN
Semper Paratus Acquisition Stock Performance
The stock's 50 day moving average price is $1.19 and its 200 day moving average price is $1.21.
Insider Activity at Semper Paratus Acquisition
In other news, CEO Ryan H. Saadi sold 1,438,206 shares of the stock in a transaction dated Monday, June 9th. The shares were sold at an average price of $1.23, for a total transaction of $1,768,993.38. Following the completion of the transaction, the chief executive officer directly owned 116,814,453 shares in the company, valued at $143,681,777.19. This represents a 1.22% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 73.24% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Semper Paratus Acquisition
A number of large investors have recently modified their holdings of the business. Geode Capital Management LLC lifted its stake in Semper Paratus Acquisition by 31.2% in the 4th quarter. Geode Capital Management LLC now owns 451,851 shares of the company's stock valued at $465,000 after purchasing an additional 107,566 shares during the last quarter. Northern Trust Corp lifted its stake in Semper Paratus Acquisition by 13.0% in the 4th quarter. Northern Trust Corp now owns 118,415 shares of the company's stock valued at $122,000 after purchasing an additional 13,595 shares during the last quarter. Nuveen LLC acquired a new stake in Semper Paratus Acquisition in the 1st quarter valued at about $97,000. XTX Topco Ltd acquired a new stake in Semper Paratus Acquisition in the 4th quarter valued at about $55,000. Finally, Barclays PLC lifted its stake in Semper Paratus Acquisition by 39.2% in the 4th quarter. Barclays PLC now owns 45,600 shares of the company's stock valued at $48,000 after purchasing an additional 12,847 shares during the last quarter.
Semper Paratus Acquisition Company Profile
(
Get Free Report)
Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.
Featured Stories
Before you consider Semper Paratus Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semper Paratus Acquisition wasn't on the list.
While Semper Paratus Acquisition currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
